Αρχική World News People With Certain Cancers Are Almost Three Times As Likely To Die...

People With Certain Cancers Are Almost Three Times As Likely To Die From COVID-19

We knew fairly quickly after COVID-19 started sweeping through the world that people who are older and/or have underlying health conditions are at a higher risk for COVID-19 than the general population.Now researchers have found that people with certain cancers have three times the risk of death as the general population.A previous study on cancer patients found that they are at an increased risk, but with only 18 patients involved, it was relatively small. Now a larger study has been done that has found not only are cancer patients are at an increased risk for complications like needing a ventilator, but they also have an increased risk of death.Specifically, patients with cancers in their blood or lungs and patients with metastatic cancer had the highest risk of death and complications.“These findings suggest that patients with cancer are a much more vulnerable population in the current covid-19 outbreak,” the authors wrote.Photo: Adobe Stock/LIGHTFIELD STUDIOS
The study was published in the American Association for Cancer Research’s peer-reviewed journal Cancer Discovery and discussed in length at the organization’s virtual annual meeting. The authors who collaborated on the study are from China, Singapore, and the United States.The study gathered information on patients from 14 different hospitals in the Hubei province in China, which is where the pandemic first reared its ugly head. The researchers analyzed 105 cancer patients and 536 non-cancer patients who were of a similar age. All had been diagnosed with COVID-19.Researchers found that cancer patients who were diagnosed with COVID-19 had a death rate roughly three times higher than the general population. In addition, cancer patients were also more likely to have “severe events” because of the virus. These include things like needing ventilators and being admitted to the ICU.Even patients who had completed treatment had an increased chance of severe COVID-19 complications compared to non-cancer patients. People in the early stages of the disease had similar risk as non-cancer patients.Photo: Adobe Stock/loris86me
Why are cancer patients more vulnerable in general, and why are some cancer patients more than others? The authors of the study hypothesize it’s due to multiple risk factors, like their age, the kind of cancer, the stage it was in, and the type of treatment they were undergoing.Cancer on its own weakens a person’s immune system and leaves them more susceptible to infection. Add in treatments that also decimate the immune system, like chemo and surgery, and they’re left pretty defenseless. Cancer patients also tend to be older, which is a known risk factor for serious complications due to COVID-19.Patients with lung cancer have impaired lung function while blood cancers like leukemia, lymphoma, and myeloma are forms of cancer that directly attack the immune system.Photo: Adobe Stock/pololia
“The findings in this study suggest that patients with cancer infected with SARS-COV-2 tend to have more severe outcomes when compared to patients without cancer. Patients with hematological cancer, lung cancer, and cancers in metastatic stages demonstrated higher rates of severe events compared to patients without cancer. In addition, patients who underwent cancer surgery showed higher death rates and higher chances of having critical symptoms,” the authors wrote.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Foodie Friday: It’s Berry Season!

July is National Berry Month! If berries aren’t part of your daily diet, now is the perfect time to start eating more of these...

No Link Between Viral Vector in Zynteglo and Acute Myeloid Leukaemia

On 23 July 2021, the European Medicines Agency (EMA) announced that its Committee for Medicinal Products for Human Use (CHMP) has endorsed findings of...

Expecting Mom Finds Pregnant Stray Cat And Gives Her A Home

A woman was 9 months pregnant when she found a pregnant stray cat. Unable to bear the thought of the fellow mom giving birth...

3 Questions Cancer Caregivers Can Ask Themselves to Help Prevent Burnout

Karen Warner Schueler is the president of her own executive coaching firm and author of The Sudden Caregiver: A Roadmap for Resilient Caregiving. For...

FDA Approval of Rylaze Will Address Drug Shortage for Childhood ALL

July 29, 2021, by NCI Staff FDA's approval of Rylaze is expected to help address a long-running shortage of the drug Erwinia asparaginase for kids...

EMA Recommends Granting a Marketing Authorisation for the Hybrid Medicine Imatinib

On 22 July 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...